Summary
In 16 diabetic patients with microangiopathy, survival of 111In-labelled autologous platelets, mean platelet volume, megathrombocyte index, spontaneous and ADP-induced platelet aggregation, platelet retention, β-thromboglobulin, von Willebrand factor and factor VIII-related antigen were measured; the splenic uptake of radioactive label was quantitated in six patients. Compared with normal subjects, increased platelet aggregation (p<0.01), von Willebrand factor (p<0.02) and factor VIII-related antigen (p<0.02) were observed. Platelet survival was shortened in two patients. It correlated inversely with the splenic radioactivity uptake (r=-0.95; p<0.01), suggesting that platelets ended their life in the spleen, not in the microcirculation. No significant relationships were found between the various tests performed, nor between these and the severity of microangiopathy or other clinical data. In spite of the evidence for altered platelet function in patients with diabetic microangiopathy, currently available tests are not specific enough to clarify the nature of these changes or their possible pathogenic significance.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bern MM (1978) Platelet function in diabetes mellitus. Diabetes 27: 342–352
Colwell JA, Halushka PV, Sarji KE, Levine J, Sagel J, Nair RMG (1976) Altered platelet function in diabetes mellitus. Diabetes 25 (Suppl2): 826–831
Diem K, Lentner C (eds) (1970) Desirable body weight of adults. Scientific Tables. TR Geigy, Basel, p 712
Peters AM, Lavender JP (1982) Factors controlling the intrasplenic transit of platelets. Eur J Clin Invest 12: 191–195
Williams ED, Merrick MV, Lavender JP (1975) The distribution and dosimetry of 111Indium-bleomycin in man. Br J Radiol 48: 275–278
Peters AM, Klonizakis I, Lavender JP, Lewis SM (1980) Use of 111In labelled platelets to measure spleen function. Br J Haematol 46: 587–593
Klonizakis I, Peters AM, FitzPatrick ML, Kensett MJ, Lewis SM, Lavender JP (1980) Radionuclide distribution following injection of 111In labelled platelets. Br J Haematol 46: 595–602
Lewis SM, Wardle J, Cousins SA, Skelly JV (1979) Platelet counting-development of a reference method and a reference preparation. Clin Lab Haematol 1: 227–237
Cagliero E, Porta M, Cousins AS, Kohner EM (1982) Increased platelet volume in diabetic retinopathy. Haemostasis 12: 293–299
Karpatkin S (1978) Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 51: 307–316
Lewis SM, Burgess BJ (1966) A stable standard suspension for red cell counts. Lab Pract 15: 305–306
Porta M, Hilgard P, Kohner EM (1980) Platelet shape change abnormalities in diabetic retinopathy. Diabetologia 18: 217–221
Porta M, Cagliero E, Kohner EM (1982) Is the pro-adhesive activity of von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness? Clin Sci 62: 239–242
Porta M, Maneschi F, White MC, Kohner EM (1981) Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy. Metabolism 30: 695–699
Laurell CB (1972) Electroimmunoassay. Scand J Lab Clin Invest 29 (Suppl 124): 21–37
Joist JH, Baker RK, Thakum ML, Welch MJ (1978) Indium-111 labelled human platelets: uptake and loss of label and in vitro function of labelled platelets. J Lab Clin Med 92: 829–836
Hawker RJ, Hawker LM, Wilkinson AR (1980) Indium-111 labelled human platelets. Optimal method. Clin Sci 58: 243–248
Heyns A du P, Lotter MG, Badenhorst PN, van Reenen OR, Pieters H, Minnaar PC, Retief FP (1980) Kinetics, distribution and sites of destruction of 111In labelled human platelets. Br J Haematol 44: 269–280
Abrahamsen AF (1968) Platelet survival studies in man (with special reference to thrombosis and atherosclerosis). Scand J Haematol 3 (Suppl): 7–53
Ferguson JC, Mackay N, Philipp JAD, Sumner DJ (1975) Determination of platelet and fibrinogen half-life with (75Se)-seleniomethionine, studies in normal and diabetic subjects. Clin Sci Mol Med 49: 115–120
Dassin E, Najean Y, Poirier O, Passa P, Bensoussan D (1978) In vivo platelet kinetics in 31 diabetic patients. Correlation with the degree of vascular impairment. Thromb Haemost 40: 83–88
Jones RL, Paradise C, Peterson CM (1981) Platelet survival in patients with diabetes mellitus. Diabetes 30: 486–489
Steele P, Rainwater J, Vogel R, Genton E (1978) Platelet suppressant therapy in patients with coronary artery disease. J Am Med Ass 240: 228–231
van Zile J, Kilpatrick M, Laimins M, Sagel J, Colwell JA, Virella G (1981) Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes 30: 575–579
Garg SK, Amorosi EL, Karpatkin S (1971) Use of the megathrombocyte as an index of the megakaryocyte number. N Engl J Med 284: 11–17
Garg SK, Lackner H, Karpatkin S (1972) The increased percentage of megathrombocytes in various clinical disorders. Ann Int Med 77: 361–369
Colwell JA, Sagel J, Crook L, Chambers A, Laimins M (1977) Correlation of platelet aggregation, plasma factor activity and megathrombocytes in diabetic subjects with and without vascular disease. Metabolism 26: 279–285
Heath H, Bridgen WD, Canever JV, Pollock J, Hunter PR, Kelsey J, Bloom A (1971) Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7: 308–315
Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J (1975) Platelet hyperaggregation and increased plasma levels of von Willebrand factor in diabetics with retinopathy. Diabetologia 11: 733–738
Sagel J, Colwell JA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Int Med 82: 733–738
Draminski-Petersen H, Gormsen J (1978) Platelet aggregation in diabetes mellitus. Acta Med Scand 203: 125–130
Corbella E, Miragliotta G, Masperi R, Villa S, Bini A, de Gaetano G, Chiumello G (1979) Platelet aggregation and antithrombin III in diabetic children. Haemostasis 8: 30–37
Shaw S, Pegrum GD, Wolff S, Ashton WL (1967) Platelet adhesiveness in diabetes mellitus. J Clin Path 20: 845–847
Mayne EE, Bridges JM, Weaver JA (1970) Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus. Diabetologia 6: 436–440
Coller BS, Zucker MB (1971) Reversible decrease in platelet retention by glass bead columns (adhesiveness) induced by disturbing the blood. Proc Soc Exp Biol Med 136: 769–771
Barrantes A, Gei O, Saenz GF, Fonseca J, Schosinski K (1980) Valoracion de la retention plaquettaria en la diabetes mellitus del adulto. Acta Med Costarricense 23: 229–234
Ludlam CA, Bolton AE, Moore S, Cash JD (1975) New rapid method for diagnosis of deep venous thrombosis. Lancet 2: 259–260
Burrows AW, Chavin SJ, Hockaday TDR (1978) Plasma thromboglobulin concentrations in diabetes mellitus. Lancet 1: 235–237
Matthews JH, O'Connor JF, Hearnshaw JR, Wood JK (1979) Beta thromboglobulin and glycosylated haemoglobin in diabetes mellitus. Scand J Haematol 23: 421–426
Betteridge DJ, Zahavi J, Jones NAG, Shine B, Kakkar VV, Galton DJ (1981) Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteins. Eur J Clin Invest 11: 273–277
Pandolfi M, Almer L-O, Holmberg L (1974) Increased von Willebrand antihaemophilic factor A in diabetic retinopathy. Acta Ophthalmol 52: 823–828
Coller BS, Frank RN, Milton RC, Gralnick HR (1978) Plasma cofactors of platelet function: correlation with diabetic retinopathy and haemoglobins A1a-c. Studies in diabetic patients and normal persons. Ann Int Med 88: 311–316
Porta M, Townsend C, Clover GM, Nanson M, Alderson AR, McCraw A, Kohner EM (1981) Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 20: 597–601
Baumgartner HR (1972) Platelet interactions with vascular structures. Thromb Diath Haemorrh 51 (Suppl): 161–176
Salzman EW (1963) Measurement of platelet adhesiveness. A simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J Lab Clin Invest 62: 724–735
Porta M (1982) Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue. Diabetologia 23: 452–455
Colwell JA, Abraira C, Anderson J, Bingham S, Kwaan H and 10 VA Medical Centers (1981) Antiplatelet agents in diabetic lower extremity vascular disease. A VA cooperative study. Diabetes 30 (Suppl1): 85 A
Scarabin PY, Samama M (1981) Effect of age on ADP-induced platelet aggregation in diabetic and non diabetic subjects. Thromb Res 22: 687–692
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Porta, M., Peters, A.M., Cousins, S.A. et al. A study of platelet-relevant parameters in patients with diabetic microangiopathy. Diabetologia 25, 21–25 (1983). https://doi.org/10.1007/BF00251891
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00251891